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X-linked mental retardation (XLMR) is a complex human disease that causes intellectual disability 1 . Causal mutations have been found in approximately 90 X-linked genes 2 ; however, molecular and biological functions of many of these genetically defined XLMR genes remain unknown. PHF8 (PHD (plant homeo domain) finger protein 8) is a JmjC domain-containing protein and its mutations have been found in patients with XLMR and craniofacial deformities. Here we provide multiple lines of evidence establishing PHF8 as the first mono-methyl histone H4 lysine 20 (H4K20me1) demethylase, with additional activities towards histone H3K9me1 and me2. PHF8 is located around the transcription start sites (TSS) of 7,000 RefSeq genes and in gene bodies and intergenic regions (non-TSS). PHF8 depletion resulted in upregulation of H4K20me1 and H3K9me1 at the TSS and H3K9me2 in the non-TSS sites, respectively, demonstrating differential substrate specificities at different target locations. PHF8 positively regulates gene expression, which is dependent on its H3K4me3-binding PHD and catalytic domains. Importantly, patient mutations significantly compromised PHF8 catalytic function. PHF8 regulates cell survival in the zebrafish brain and jaw development, thus providing a potentially relevant biological context for understanding the clinical symptoms associated with PHF8 patients. Lastly, genetic and molecular evidence supports a model whereby PHF8 regulates zebrafish neuronal cell survival and jaw development in part by directly regulating the expression of the homeodomain transcription factor MSX1/MSXB, which functions downstream of multiple signalling and developmental pathways 3 . Our findings indicate that an imbalance of histone methylation dynamics has a critical role in XLMR.
XLMR affects 1-4 out of 2,000 males, causing intellectual disability (intelligence quotient (IQ) ,70) 1 . Approximately 1/3 of them are syndromic patients in that they also have additional clinical symptoms including defects in craniofacial, muscular and haematopoietic development 1 . About 25% of the XLMR genes identified by human genetic studies are predicted to encode nuclear proteins, including transcriptional regulators and chromatin remodelling proteins 2, 4 . However, molecular mechanisms by which these proteins regulate biological processes relevant to the disease remain incompletely understood.
PHF8 belongs to a subfamily of JmjC domain-containing proteins that also includes KIAA1718 (also known as JHDM1D) and PHF2. All three proteins share a similar domain structure with an amino terminal PHD finger adjacent to the catalytic JmjC domain (Fig. 1a) , predicting that they are candidate histone demethylases. We used nucleosomes as substrates and identified a novel H4K20me1-specific demethylase activity for PHF8 and KIAA1718, with additional activities towards H3K9me1/2 and H3K27me2, but not H4K20me2/3 or trimethylated H3K9, 27 and 36 (Fig. 1b) . However, when histone octamers were used as substrates, we were unable to detect the H4K20me1 demethylase activity (Supplementary Fig. 2 and Supplementary Table 1) , consistent with a number of recent reports that identified PHF8 as an H3K9me1/2 and H3K27me2 specific demethylase [5] [6] [7] [8] [9] . This discrepancy could be due to the use of nucleosomes versus histone octamers as substrates, and, as such, is not unprecedented. For instance, a number of histone methyltransferases have been shown to only methylate nucleosomal substrates or to methylate a specific lysine residue only in the nucleosomal context 10, 11 . Importantly, the above in vitro demethylation reactions were also analysed by mass spectrometry, which confirmed the western blot results (Fig. 1c-h and Supplementary Fig. 1 ). Furthermore, a point mutation in the catalytic domain (phenylalanine to serine, F279S) abolished PHF8 demethylase activities (Fig. 1b) , indicating that the reduction of the H3K9me1/2 and H4K20me1 signals by wild-type PHF8 was due to its demethylase activity. The F279S mutation has been found in several male XLMR patients from a Finnish family 12 , indicating the importance of the demethylase activity in PHF8-associated mental retardation.
We next investigated the impact of PHF8 on the global H4K20 and H3K9 methylation states in the cells. PHF8 overexpression in U2OS but not HeLa cells, which express a high level of PHF8 (Supplementary Fig. 3 ), resulted in a significant reduction of H3K9me2 (but not H3K9me1), and only a slight reduction of the global level of H4K20me1 (,10%) ( Supplementary Fig. 4 and Supplementary Table 2) . Although overexpression or RNA interference (RNAi) of PHF8 in HeLa cells did not affect the global levels of H4K20me1 and H3K9me1 assayed by western blotting (Supplementary Fig. 5a ), we did observe an increase in the overall H4K20me1 level in the late G2/M and early G1 stages of the cell cycle when we inhibited PHF8 expression by RNAi (Supplementary Fig. 5b ). This is consistent with the previous reports that H4K20me1 is cell-cycle-regulated 13, 14 and provides further support that PHF8 regulates H4K20me1 in vivo. Interestingly, inhibition of PHF8 also reduced cell proliferation ( Supplementary Fig. 6 ), indicating a possible role for PHF8 in regulation of cell growth via histone demethylation.
To identify the genomic locations of PHF8, we performed ChIPSeq (chromatin immunoprecipitation followed by DNA deep sequencing). We obtained 17,293 peaks in HeLa cells after IgG normalization. Of those, 8,077 peaks representing 7,469 RefSeq genes are mapped to within 2.5 kilobases of TSS (Supplementary Table 3) as well as 9,824 potential PHF8 binding events in the gene bodies (23.5%) and intergenic regions (33.3%) (Fig. 2a) . This pattern of PHF8 genomic distribution was corroborated by ChIP-chip analysis. Importantly, the majority of the PHF8 binding signals identified by ChIP-chip were erased by PHF8 RNAi, supporting the specificity of the PHF8 binding events detected by the PHF8 antibody (Supplementary Figs 3, 7 and Supplementary Table 4) . Interestingly, the pattern of PHF8 binding around TSS (Fig. 2a) resembles that of H3K4me3 (refs 15, 16) , consistent with the fact that the PHD domain of PHF8 binds H3K4me3 (refs 5, 17) . Point mutations (Y7A, W29A, Y7A/Y14A, W29A/Y14A) that abolished binding of PHF8 to H3K4me3 in vitro disrupted its localization in vivo ( Supplementary  Fig. 8 ), indicating that PHF8 TSS localization may be dependent on its PHD domain recognizing H3K4me3. Importantly, analysis of the ChIP-Seq and gene expression microarray data (Supplementary Table 6 ) show that PHF8-binding events are positively correlated with gene expression (Fig. 2b) , indicating that PHF8 binds H3K4me3 and functions to promote gene transcription.
We next used ChIP-Seq to investigate histone methylation regulation by PHF8 at its direct loci using HeLa cells stably expressing either control or PHF8 shRNA. We found that PHF8 depletion caused a modest albeit significant increase in H4K20me1 and H3K9me1 at the PHF8 TSS target loci (Fig. 2c, e) , compared with the regions not bound by PHF8 (P value ,0.01), indicating that PHF8 regulates transcription by demethylating H4K20me1 and H3K9me1. Unlike H4K20me1 and H3K9me1, H3K9me2 levels remained unchanged (Fig. 2g) . Interestingly, for the 9,824 non-TSS PHF8 sites, we found that reduction of PHF8 is instead correlated with an increase in H3K9me2 (P value ,0.01) (Fig. 2h ), but not H3K9me1 or H4K20me1 (Figs 2d and f) , indicating that PHF8 may regulate non-TSS regions via demethylation of H3K9me2. Consistently, a recent study reported PHF8 regulation of rDNA transcription via demethylation of H3K9me2 (ref. 5) . The finding that PHF8 may exhibit differential substrate specificities at different genomic locations (TSS versus non-TSS) implies that additional factors are involved in the regulation of PHF8 demethylase specificity in vivo.
To confirm the ChIP-Seq histone modification data, we initially focused on three TSS-bound PHF8 target genes, FBXO7, TFAP2C and NCOA3, and first confirmed PHF8 binding near TSS (amplicon 2) by conventional ChIP assays (Fig. 3a, b) . Inhibition of PHF8 resulted in upregulation of H4K20me1 and H3K9me1 at amplicon 2 of the target genes (Fig. 3b) . In some instances, we also observed an increase in H4K20me1 and H3K9me1 in amplicons numbers 1 and 3 for reasons that are currently unclear. In contrast, we found no appreciable changes in H3K9me2, H3K27me1/2 or H3K36me1/2 ( Supplementary Fig. 9 ), many of which are also substrates of PHF8 in vitro (refer to Fig. 1 and Supplementary Figs 1 and 2) . We also did not observe changes in histone H3, indicating that the increase in H4K20me1/H3K9me1 is not due to an increase in nucleosome density ( Supplementary Fig. 9 ). We investigated further an additional seven PHF8 target genes and found that H4K20me1 and H3K9me1 increase for some if not all of these targets ( Supplementary Fig. 11 ). We next investigated the impact of PHF8 inhibition on the expression of these three target genes. As shown in Fig. 3c , consistent with the bioinformatics analysis (Fig. 2b ) implicating PHF8 as a positive regulator of transcription, their expression was downregulated in PHF8 RNAi cells, restored by wild-type PHF8 but not by the patient F279S mutation or the H3K4me3-binding defective PHD finger mutant (Y7A, W29A). The expression of the additional seven genes was similarly reduced on PHF8 inhibition ( Supplementary Fig. 11 ). Taken together, these data indicate that PHF8 demethylates H4K20me1 and H3K9me1 both in vitro and in vivo, and that both H3K4me3-binding and catalytic functions of PHF8 are important for its ability to positively regulate gene expression. Although H4K20me1 has been found downstream of TSS on active genes 16, 18 , it has also been associated with repression and recruitment of L3MBTL1 (also known as L3MBTL), which preferentially binds mono-and dimethylated lysines including H4K20me1 and H3K9me1 (ref. 19 ) and induces chromatin compaction to negatively regulate gene expression further 20 . On PHF8 knockdown, we also observed a corresponding increase of L3MBTL1 at amplicon 2 but not amplicons 1 and 3 ( Fig. 3b and Supplementary Fig. 10 ). This is interesting in light of the fact that the H4K20me1 increase in PHF8 RNAi cells extends beyond amplicon 2, indicating that other factors, H3K9me1 H3K9me1
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H3K9me2 H3K9me2 LETTERS in addition to H4K20me1, are involved in determining L3MBTL1 recruitment. Additionally, we observed a reduction of H3K4me3, a mark that is associated with active genes, consistent with these genes being in a transcriptionally repressed state ( Fig. 3b and Supplementary Fig. 10 ). Taken together, these findings support the model that PHF8, when bound to the TSS of the target genes, positively regulates transcription by demethylating H3K9me1 and H4K20me1.
To address the biological function of PHF8, we turned to zebrafish where PHF8 is evolutionarily conserved (Supplementary Fig. 11 ). zPHF8 expression was first detected at 14 h post-fertilization (h.p.f.) in the head and tail regions (Supplementary Fig. 12 ), but starting at 1 day post-fertilization (d.p.f.), zPHF8 was found mostly in the head region. zPHF8 expression was also detectable in the jaw of the embryo at 3 d.p.f. Injection of a zPHF8 morpholino caused delay in brain development at 24 h.p.f. (Fig. 4A, compare panel b with a) , and apoptosis in the developing brain and the neural tube at 30 h.p.f. (Fig. 4C, compare  panel b with a) . Significantly, this apoptosis can be rescued by reintroduction of wild-type but not catalytically inactive zPHF8 (Fig. 4C, compare panels c, d with a, b) . However, whether PHF8 regulates cell death by directly modulating the apoptotic machinery or indirectly through regulation of cell proliferation remains to be investigated. Furthermore, it remains to be seen whether PHF8 also has a role in post-mitotic mature neurons. In addition to apoptosis in the developing brain, we also detected significant differences in craniofacial development between control and zPHF8-morpholino-injected embryos at 3, 4 and 7 d.p.f., with the most pronounced defect being the absence of a lower jaw (Fig. 4B , compare panel a with b, Supplementary Fig. 13 ). To understand better the craniofacial developmental abnormality, we used Alcian blue to visualize the extent of cartilage development in these embryos. We found that the 1st through 5th pharyngeal arches were all either developmentally affected or were absent upon zPHF8 inhibition (Fig. 4B, compare panels d, f with c, e) . Specifically, the 1st pharyngeal arch had not migrated to the full extent of the lower jaw and the 2nd pharyngeal was inverted. The 3rd through 5th pharyngeal arches were also significantly under-developed. Importantly, wild-type but not catalytically inactive zPHF8 showed significant rescue of the craniofacial defects induced by the zPHF8 morpholino (Fig. 4B, Supplementary  Table 5 ). Collectively, these findings identified a critical role of zPHF8 in zebrafish brain and craniofacial development, in a manner that is dependent on its demethylase activity.
The msh/Msx gene family encodes homeodomain transcription factors that act downstream of the TGF-b (tumour growth factor beta), BMP (bone morphogenetic protein) and WNT (Wingless integration) signalling pathways and has important roles in many developmental processes including craniofacial and neural development 3 . Zebrafish has five homologues, msxa through msxe, that constitute the zebrafish orthologues of the tetrapod MSX1, MSX2 and MSX3 genes 21 , of which MSX1 was identified as a PHF8 direct target ( Supplementary Fig. 14a, b) . Interestingly, a msxb morpholino produced craniofacial deformities similar to those seen in a zPHF8 morphant 22 . We therefore investigated whether msxb was regulated by zPHF8 and whether it functions to mediate the role of zPHF8 in zebrafish craniofacial development. We found that the msxb transcript level was reduced to 40% of wild-type level in embryos injected with a zPHF8 morpholino (Supplementary Fig. 14c ). The msxb transcript was largely restored to wild-type levels in the animals rescued with zPHF8 mRNA encoding wild type, but not with a catalytically inactive form of the zPHF8 protein ( Supplementary Fig. 14c) . Importantly, injection of msxb mRNA also significantly corrected the craniofacial defects induced by the zPHF8 morpholino (Fig. 4B , compare panels k, l with a, c and g, h). Although the rescue was not complete, the lower jaw developed better and the 2nd pharyngeal arch was no longer inverted (Fig. 4B , compare panels l with d and h, and data not shown). Similarly, the apoptosis seen in the developing brain and neural tube was also suppressed by forced expression of msxb (Fig. 4C, panel e) . These findings raise the possibility that zPHF8 may control neuronal cell survival and craniofacial development at least in part by regulating msxb expression. However, it is likely that msxb is not the only PHF8 target gene that mediates PHF8 biology. Consistent with this idea, bioinformatics analysis of the expression microarray data from HeLa cells identified additional potential PHF8 target genes in a number of pathways including RA (retinoic acid) and Notch signalling pathways (Supplementary Table  6 ), both of which have been previously shown to have a role in neural and craniofacial development 23, 24 and therefore may also be involved in PHF8 biological functions. In addition, the PHF8 direct target genes (FBXO7, NCOA3 and TFAP2C) discussed earlier (Fig. 3 ) also function in neural development [25] [26] [27] . Lastly, ChIP-Seq/ChIP-chip identified many XLMR genes as potential PHF8 direct targets ( Supplementary Fig. 15 ), consistent with a recent report 7 . This finding raises the interesting possibility of a connection between PHF8 and other XLMR gene products in regulating cognitive functions. However, given that the ChIP-Seq data were obtained from heterologous cells, whether PHF8 regulation of other XLMR genes is physiologically and pathologically relevant remains to be investigated.
In conclusion, we have identified the XLMR gene PHF8 to encode a novel H4K20me1 and H3K9me1/2 demethylase, and provided insights into the molecular mechanisms by which PHF8 regulates histone methylation the and gene transcription. The identification of a role for PHF8 in zebrafish brain apoptosis and craniofacial development indicates a potential biological basis for the involvement of PHF8 mutations in mental retardation and craniofacial deformities. Importantly, our finding of PHF8 as a histone demethylase whose mutations are correlated with XLMR supports the emerging theme of a critical link between histone methylation dynamics in X-linked mental retardation.
METHODS SUMMARY
In vitro demethylation assay. Glutathione S-transferase (GST)-tagged PHF8 and KIAA1718 proteins and full-length PHF8 protein were purified from bacteria and from insect Sf9 cells. Demethylation assay was carried out with 0.6 mg of histone octamers or 1 mg mono-nucleosomes in demethylation buffer (50 mM HEPES-KOH, pH 7.9, 50 mM KCl, 1 mM MgCl 2 , 100 mM (NH 4 ) 2 Fe(SO 4 ) 2 ?6(H 2 O), 1 mM a-ketoglutarate, and 2 mM ascorbic acid] for 4 h at 37uC. Western blot was performed with antibodies recognizing specific modifications. ChIP-qPCR. Chromatin was prepared from HeLa stable cell lines expressing pBabe-control or PHF8 shRNAs and was sonicated to the range of 0.6 to 1.2 kb. ChIP-chip and ChIP-qPCR experiment for PHF8 were carried out with PHF8 antibody (Ab36068) in the buffer (50 mM HEPES, 500 mM NaCl, 1 mM EDTA, 1% triton, 0.1% deoxycholate-Na). For conventional ChIP of selected histone marks, 100-200 mg of chromatin was used and the final ChIP DNA was dissolved in 100 ml H 2 O. ChIP DNA (2 ml) and input DNA were used for real time PCR. ChIP-chip and ChIP-Seq are essentially described in Methods. Rescue experiments. Double stable HeLa cell lines were established with coexpressed pOZ-FH, or pOZ-FH-PHF8 (wild type or mutant) and pBabe shRNAs (control or PHF8 RNAi1). Reverse transcription was performed on 200 ng RNA followed by real-time PCR. Zebrafish experiments. Whole-mount in situ hybridization was performed using digoxigenin-labelled antisense RNA probes. zPHF8 antisense morpholino was injected with at one-cell stage. Pharyngeal arch and apoptosis were monitored by Alcian blue and acridine orange staining, respectively.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
Vectors and antibodies. Full-length PHF8 (1-1024) and (60-1024) were amplified by RT-PCR and inserted into the XhoI/XbaI sites of pcDNA3-C-HA vector. Fulllength PHF8 was also inserted into XhoI/NotI sites of pOZ-N-Flag-HA vector. Full-length KIAA1718 was also PCR-amplified and cloned into Gateway entry vector and pcDNA3-C-HA vector. GST-PHF8 (1-447), GST-PHF8 (1-76), GST-KIAA1718 (1-488) were constructed by inserting the PCR-amplified fragments into pGEX-4T-3 vector. F279S mutation was introduced into pcDNA3-PHF8-HA, GST-PHF8 (1-447) and pOZ-N-Flag-HA-PHF8 vectors by mutagenesis. Single (Y5A, Y14A, W29A) and double mutations (Y14A,W29A and Y5A,Y14A) were generated in GST-PHF8 (1-76), pcDNA3-PHF8-HA and pOZ-N-Flag-HA-PHF8 vectors. Control 28 and PHF8 shRNAs were constructed in pBabe-U6-puro vector 28 with the passenger strand (59 to 39) sequences for PHF8 shRNA1 (ORF): GCTTCATGATCGAGTGTGACA, PHF8 shRNA2 (39UTR): GGCCTAGAAATGCCAACTTCA. PHF8 silent mutations that confer shRNA1 resistance were introduced into pOZ -N-Flag-HA-PHF8wt, F278S, and Y5W,W29A vectors. To generate Bac-N-Blue (BB)-Flag insect cell expression vectors, full-length PHF8 was first cloned into the Gateway Entry vector (Invitrogen) and subcloned into a Gateway Flag-baculoviral expression vector. All antibodies are listed in Supplementary Table 7 . The Abcam PHF8 antibody (ab36068) recognizes only the HA-tagged PHF8 at about 145 kDa, but not HA-KIAA1718 which is at 110 kDa ( Supplementary Fig. 4 ). The Active Motif PHF8 antibody was generated using His-tagged PHF8 (539-689) as an immunogen. Both antibodies detect a single band at about 145 kDa, which was abolished by PHF8 RNAi, indicating that they recognize endogenous PHF8 ( Supplementary  Fig. 4 ). PHF8 RNAi in HeLa cells. PHF8 stable knockdown and control HeLa cell lines were established by transfecting HeLa cells with pBabe-PHF8 shRNA1 or pBabecontrol shRNA 28 vectors. The transfectants were selected with puromycin (1 mg ml 21 ) until the cells were stabilized. The stable cell lines were transfected again with the corresponding shRNA for an additional 3 days for ChIP chromatin preparation, gene expression (microarray and qRT-PCR) and cell cycle analysis. The knockdown efficiency was monitored by western blot with an anti-PHF8 antibody (Active Motif). Mass spectrometry. In vitro demethylation assay using GST and GST-PHF8 (1-447) was performed on nucleosomes (1 mg per reaction), which were isolated from HeLa cells. To compare histone PTMs (post-translational modifications) from those reacted nucleosomes, we used a chemical isotopic labelling approach described recently 29 . In brief, equal amounts of control and PHF8-treated total nucleosome samples were derivatizated using D0-proionic anhydride followed by trypsin digestion at a substrate enzyme ratio of 20:1 for 5 h at 37 uC. Samples were quenched by acidification with acetic acid and then labelled on the peptide N termini using either D0-or D5-propionic anhydride followed by desalting on homemade STAGE tips as reported earlier 30 . Desalted peptides were loaded onto a fused silica capillary column (75 mm) packed with C18 resin constructed with an ESI tip by an Eksigent AS-2 autosampler (Eksigent Technologies). Peptides were eluted from the C18 material at a flow rate of ,200 nl min 21 using a 5-40% solvent B in 60 min gradient (solvent A, 0.1 M acetic acid; solvent B, 70% MeCN in 0.1 M acetic acid) into an Orbitrap mass spectrometer (ThermoFisher Scientific) as described previously 29 . Gene expression experiments and microarray analysis. For target gene expression and rescue experiments, PHF8 shRNA1-resistant mutant pOZ-FHwild-type PHF8, PHF8(F278S), PHF8(Y5A, W29A) and empty vectors were packed into retrovirus as described previously 28 . HeLa cells were infected with the virus and selected with anti-IL-2a receptor, which was conjugated with Dynal beads. The stable cell lines were transfected with control or PHF8 shRNA1 and subjected to puromycin selection. Reverse transcription was performed using 100 ng RNA and poly(dT) primer, real time PCR with Light cycler 480 were done with the primers listed in Supplementary Table 8 . Microarray analysis was performed on Human Whole Genome OneArray by Phalanx Biotech Group. RNA was prepared from three independent control and PHF8 RNAi HeLa cells. Each RNA sample was subjected to replicate hybridizations to the array. Based on qRT-PCR analysis of 10 PHF8 target genes, which were downregulated from 230% to 270% in PHF8 RNAi cells, we chose 230% and P , 0.05 as cutoff for downregulated genes. For upregulated genes, we chose twofold and P , 0.05. Purification of GST fusion proteins and Flag-PHF8. GST fusion proteins were produced from Rosetta bacteria strain and purified with glutathione Sepharose 4B (GE healthcare). Briefly, Rosetta bacteria transformed with the corresponding plasmids were grown until absorbance reached 0.8 at 595 nm and induced with 500 mM IPTG for 5 h at room temperature. The bacteria were collected and lysed with 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 150 mM NaCl and 0.2% Triton. GST-fused proteins were eluted with 50 mM Tris-HCl and 20 mM glutathione.
The Flag-PHF8 was expressed in Sf9 cells using BAC-N-BLUE baculoviral expression system (Invitrogen). Cells were lysed in 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% NP-40, 0.2% Triton X-100, 1 mM DTT, 1 mM PMSF and Protease Inhibitor Cocktail (Roche). Recombinant proteins were immobilized on Flag M2 affinity gel (Sigma), washed with buffer W (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 8.0% glycerol, 1 mM DTT, 0.01% NP40), and eluted in buffer W containing 100 mg ml 21 of 33Flag peptide (Sigma). Histone peptide binding assay. GST-fused PHF8 (1-76) and corresponding mutants were purified as described above. Five micrograms of purified proteins were incubated with 0.2 mg of biotinylated histone peptide in 100 ml of the binding buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.05% NP-40, 0.3 mg ml 21 BSA) overnight at 4 uC. Protein-peptide complexes were pulled down with streptavidin beads (Upstate), washed five times with binding buffer and subjected to SDS-PAGE and Coomassie blue staining. Immunofluorescence and antibodies. HA-tagged PHF8 constructs were transfected into U2OS or HeLa cells for 24 h and plated onto coverslips in six-well plates at 3 3 10 5 cells per well. After 24 h, cells were fixed with 4% paraformaldehyde, permeabilized (0.2% Triton X-100 in PBS), and blocked with 1% BSA. The coverslips were incubated at 4 uC overnight with corresponding primary antibodies, washed, and incubated with the corresponding secondary antibodies for 1 h at room temperature. The coverslips were then washed, mounted with Vectashield (Vector Laboratories), and analysed with a fluorescence microscope (Nikon E600) using a 360 objective. Images were acquired and processed with Openlab 3.1.5 software. Primary antibodies are detailed in the antibody table. Alexa 594-conjugated donkey anti-rabbit and Alexa 488-conjugated goat antimouse secondary antibodies (Molecular probes) were used at 1:10,000. Hoechst 33342 was used to stain the nucleus. qChIP (conventional ChIP followed by real time PCR) and ChIP-chip. Hela stable cells (Control or PHF8 RNAi) from a p150cm plate were cross-linked with 1% formaldehyde and quenched with 0.125 M glycine. Cells were washed with cold PBS and then lysed with lysis buffer (50 mM HEPES, 500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% deoxycholate-Na) complemented with Protease Inhibitor Cocktail (Roche). DNA fragmentation was performed with a Misonix 3000 sonicator using 1 ml cell lysate with four cycles of 25 s on and 45 s off. In qChIP, 200 mg of chromatin were beads (Protein A or G beads) cleared and incubated with 4 mg of PHF8 or 2 mg of the histone antibodies at 4 uC. Protein A or G beads (25 ml) were added for 1 h and the complexes were washed five times with the lysis buffer and once with RIPA buffer (50 mM HEPES pH 7.6, 300 mM LiCl, 1 mM EDTA, 0.5% NP40 and 0.7% deoxycholate-Na). The immunoprecipitants were de-cross-linked at 65 uC overnight. The immunoprecipitated DNA was dissolved in 50 ml H 2 O. Input DNA (1%) and 2 ml of ChIP DNA were used for real time PCR. The primers for qChIP are shown in Supplementary Table 9 . ChIP-chip. Chromatin from HeLa cells, control RNAi and two PHF8 RNAi HeLa cells were prepared as described above. ChIP-chip was performed on an Agilent 244K array (AMADID 14841; G4495A) that tiles across the genome from chromosome 20 (045004127) to chromosome X (025615738) according to the Agilent Mammalian ChIP-on-chip protocol (Version 9.2) (http://www.chem. agilent.com/Library/usermanuals/Public/ChIP-on-chip_Mammalian_9.2.pdf). Briefly, input and the immunoprecipitated DNA using PHF8-specific antibody (Ab36068) undergo linker ligations and two rounds of ligation-mediated (LM)-PCR. The LM-PCR products from input and ChIP DNA were labelled with Cy3 and Cy5, respectively, and hybridized to the Agilent 244K array. Enrichments were obtained by extracting the Cy5 (ChIP DNA) signal over Cy3 (input DNA) signal. To identify the significant binding events among the ChIP-chip data, we first performed Lowess normalization, and then applied the ''Pre-defined Peak Shape Detection 2.0'' algorithm provided within the ChIP Analytics software package from Agilent Technologies, using the default algorithm parameters, a score threshold of 2.0, and applying the option to repeat the peak-finding calculation after optimizing the peak-shape model. Associations of the resulting binding events with genes were determined by comparing predicted peak centres to transcription start sites as defined by the ''refFlat'' table of RefSeq genes 31 for Hg18 provided at the UCSC Genome Browser Database 32 . ChIP-Seq (chromatin immunoprecipitation followed by DNA sequencing). Control and PHF8 shRNA knockdown HeLa cells were described above. For PHF8 ChIP-Seq, cells were cross-linked with 1% formaldehyde, and quenched with 0.125 M glycine. Cross-linked chromatin templates were generated as described in ref. 33 . Cells (20 3 10 7 ) were immunoprecipitated with 8 mg of anti-PHF8 antibody (ab36068). For H3K9me2,1 and H4K20me1, we generated native chromatin from 10 7 cells with micrococcal nuclease to gain mainly mononucleosomes for each ChIP 34 . ChIP-Seq library construction, Illumina sequencing, and data analyses were performed as described previously 33, 34 . Briefly, sequence reads of PHF8, H3K9me1, H3K9me2 and H4K20me1 were mapped to the human genome (hg18) using Solexa Analysis Pipeline. All uniquely matching reads were retained. PHF8-enriched regions were predicted with SICER
